Main Street Research’s Edwards Lifesciences EW Stock Holding History

Main Street Research’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,213	Closed	-$204K	–	111
2024 Q2	$204K	Buy	2,213 +13	+0.6%	+$1.15K	0.01%	99
2024 Q1	$210K	Buy	+2,200	New	+$185K	0.01%	100
2023 Q3	–	Sell	-2,200	Closed	-$208K	–	95
2023 Q2	$208K	Buy	+2,200	New	+$191K	0.03%	89
2022 Q3	–	Sell	-2,200	Closed	-$209K	–	101
2022 Q2	$209K	Hold	2,200	–	–	0.05%	82
2022 Q1	$259K	Hold	2,200	–	–	0.02%	103
2021 Q4	$285K	Hold	2,200	–	–	0.02%	109
2021 Q3	$249K	Hold	2,200	–	–	0.02%	122
2021 Q2	$228K	Buy	+2,200	New	+$207K	0.02%	128
2021 Q1	–	Sell	-2,311	Closed	-$211K	–	131
2020 Q4	$211K	Buy	+2,311	New	+$192K	0.02%	117

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Main Street Research's EW Position: Q3 2024 in Review

Main Street Research sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 2,213 shares — an estimated $204K sold.

Main Street Research first reported a position in EW in Q4 2020 and held it in 9 quarters. The position peaked at $285K in Q4 2021. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

Main Street Research reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
Main Street Research sold 2,213 Edwards Lifesciences shares in Q3 2024, an estimated $204K.
Main Street Research first reported a position in Edwards Lifesciences in Q4 2020 and held it in 9 quarters.
Main Street Research's Edwards Lifesciences position peaked at $285K in Q4 2021.
1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Main Street Research's 13F filing for Q3 2024, filed 12 Nov 2024.